Please assess the completion status of the following clinical trial:

Trial Title: Clinical Evaluation of a Small Aperture Extended Depth of Focus Intraocular Lens

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Minimum 22 years of age;~2. Able to comprehend and have signed a statement of informed consent;~3. Availability, willingness, ability and sufficient cognitive awareness to comply with examination procedures and study visits;~4. Planned crystalline lens removal by phacoemulsification, with or without femtosecond laser-assisted extraction, and posterior chamber IOL implantation in both eyes;~5. Cataractous lens changes as demonstrated by best-corrected visual acuity (BCDVA) of 20/40 or worse either with or without a glare source present;~6. Potential for postoperative BCDVA of 20/25 or better in each eye~7. Clear intraocular media, other than cataract.~Exclusion Criteria:~1. Requiring an IC-8 intraocular lens outside the available spherical power range~2. Pharmacologically dilated pupil size less than 6 mm in either eye;~3. Inability to achieve stable keratometric readings for contact lens wearers~4. Irregular astigmatism in either eye;~5. Preoperative corneal astigmatism \> 1.50 diopters in either eye~6. Active or recurrent anterior segment pathology~7. Presence of ocular abnormalities other than cataract as specified in the protocol~8. Diagnosis of dry eye in which patients are unable to maintain eye comfort or adequate vision even with dry eye medication;~9. Congenital cataracts;~10. Previous corneal or intraocular surgery~11. History of ocular trauma or ocular conditions expected to require retinal laser treatment or other surgical intervention;~12. Systemic conditions as specified in the protocol;~13. Patient is pregnant, plans to become pregnant, or is lactating~14. Concurrent participation or participation in any clinical trial up to 30 days prior to preoperative visit.

- Gender: ALL
- Minimum Age: 22 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- IC-8 IOL Group (Type: EXPERIMENTAL): A monofocal IOL (TECNIS ZCB00, ZCT150 or ZCT225 or AcrySof IQ SA60WF, SA6AT3 or SA6AT4) implanted in the first eye. The AcuFocus IC-8 IOL implanted in the second eye.
- Control Group (Type: ACTIVE_COMPARATOR): A monofocal IOL (TECNIS ZCB00, ZCT150 or ZCT225 or AcrySof IQ SA60WF, SA6AT3 or SA6AT4) bilaterally implanted.

Based on this trial design, predict the completion outcome and termination type (if applicable).